Latest filing published 20 Mar 2026 for CVS HEALTH Corp, €36k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by John E. Gallina span 3 companies, the busiest being Elevance Health, Inc., Arrive AI Inc. and CVS HEALTH Corp. In total, 36 filings cover trades dated from 1 June 2016 to 19 March 2026.
The open-market record consists of 3 sales worth €4.6M, with no purchase. Outside the open market, there are 24 share grants and 5 option exercises.
Most recently, on 20 March 2026, the filings show a share grant worth €36k in CVS HEALTH Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations